Literature DB >> 23574770

Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications.

Adam J Cole1, Charles M Quick.   

Abstract

Endometrial endometrioid adenocarcinoma (EEC) is the most common malignancy of the female genital tract, partly attributable to chronic estrogen exposure secondary to increased obesity rates. Tumor stage, which in most cases is based on depth of invasion (DOI), is of critical importance in determining if additional treatment is needed. However, the array of invasive morphologies within the spectrum of ECC can make the determination of DOI difficult. Several morphologic patterns of invasion have been described, including diffusely infiltrating irregular glands, "broad front" (or pushing border), adenoma malignum, adenomyosis-like, and microcystic, elongated, and fragmented glands. EEC may often contain a mixture of invasive patterns, which can further complicate evaluation of these common tumors. Recognition of these patterns may lead to more accurate staging, but perhaps more importantly, some patterns may be associated with adverse prognostic features. The purpose of this review is to highlight the various invasive patterns of EEC and note their unique pitfalls and prognostic implications in an effort to improve staging accuracy and treatment and follow-up for the thousands of women affected by this disease each year.

Entities:  

Mesh:

Year:  2013        PMID: 23574770     DOI: 10.1097/PAP.0b013e31828d17cc

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  10 in total

1.  CTHRC1 promotes M2-like macrophage recruitment and myometrial invasion in endometrial carcinoma by integrin-Akt signaling pathway.

Authors:  Lu-Ying Li; Ke-Min Yin; Yi-Han Bai; Zhi-Gang Zhang; Wen Di; Shu Zhang
Journal:  Clin Exp Metastasis       Date:  2019-05-22       Impact factor: 5.150

2.  The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion: A Single Institution Report of 464 Consecutive FIGO Grade 1 Endometrial Endometrioid Adenocarcinomas.

Authors:  Amy S Joehlin-Price; Kelsey E McHugh; Julie A Stephens; Zaibo Li; Floor J Backes; David E Cohn; David W Cohen; Adrian A Suarez
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

3.  Association between Morphological Patterns of Myometrial Invasion and Cancer Stem Cell Markers in Endometrial Endometrioid Carcinoma.

Authors:  Ji Y Park; Daegy Hong; Ji Young Park
Journal:  Pathol Oncol Res       Date:  2017-10-08       Impact factor: 3.201

4.  Reproducibility of measurement of myometrial invasion in endometrial carcinoma.

Authors:  Louis J M van der Putten; Koen van de Vijver; Carla Bartosch; Ben Davidson; Sonia Gatius; Xavier Matias-Guiu; W Glenn McCluggage; Gemma Toledo; Anneke A M van der Wurff; Johanna M A Pijnenborg; Leon F A G Massuger; Johan Bulten
Journal:  Virchows Arch       Date:  2016-10-27       Impact factor: 4.064

5.  Myoinvasive Pattern as a Prognostic Marker in Low-Grade, Early-Stage Endometrioid Endometrial Carcinoma.

Authors:  Ignacio Ruz-Caracuel; Jorge L Ramón-Patino; Álvaro López-Janeiro; Laura Yébenes; Alberto Berjón; Alicia Hernández; Alejandro Gallego; Victoria Heredia-Soto; Marta Mendiola; Andrés Redondo; Alberto Peláez-García; David Hardisson
Journal:  Cancers (Basel)       Date:  2019-11-22       Impact factor: 6.639

6.  Prognositc Significance of Microcystic Elongated and Fragmanted (MELF) Myometrial Invasion Pattern: A Retrospective Study

Authors:  Oguzhan Okcu; Gokce Askan; Bayram Sen; Cigdem Ozturk; Seda Duman Ozturk; Gulname Fındık Guvendi
Journal:  Medeni Med J       Date:  2022-09-21

7.  IFITM1 Is Superior to CD10 as a Marker of Endometrial Stroma in the Evaluation of Myometrial Invasion by Endometrioid Adenocarcinoma.

Authors:  Aurelia Busca; Bojana Djordjevic; Ana Giassi; Carlos Parra-Herran
Journal:  Am J Clin Pathol       Date:  2016-03-21       Impact factor: 2.493

8.  The clinicopathological characteristics and survival outcomes of endometrial carcinoma coexisting with or arising in adenomyosis: A pilot study.

Authors:  Xiaopei Chao; Ming Wu; Shuiqing Ma; Xianjie Tan; Sen Zhong; Yalan Bi; Huanwen Wu; Jinghe Lang; Lei Li
Journal:  Sci Rep       Date:  2020-04-06       Impact factor: 4.379

9.  Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma.

Authors:  Ignacio Ruz-Caracuel; Álvaro López-Janeiro; Victoria Heredia-Soto; Jorge L Ramón-Patino; Laura Yébenes; Alberto Berjón; Alicia Hernández; Alejandro Gallego; Patricia Ruiz; Andrés Redondo; Alberto Peláez-García; Marta Mendiola; David Hardisson
Journal:  Virchows Arch       Date:  2021-08-21       Impact factor: 4.064

10.  Peritumoral Enhancement for the Evaluation of Myometrial Invasion in Low-Risk Endometrial Carcinoma on Dynamic Contrast-Enhanced MRI.

Authors:  Tingting Cui; Feng Shi; Bei Gu; Yanfang Jin; Jinsong Guo; Chao Zhang; Jie Ren; Yunlong Yue
Journal:  Front Oncol       Date:  2022-01-17       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.